Company recalls anticoagulant
SCA Pharmaceuticals has recalled 10 lots of compounded heparin sodium, an anticoagulant packaged in 500 mL or 1000 mL intravenous bags, the Food and Drug Administration announced yesterday. The bags contain the undeclared benzyl alcohol, a preservative that can cause serious adverse reactions in premature and low birth weight infants.
Related News Articles
Headline
In this conversation, Terry Scoggin, CEO of Titus Regional Medical Center, discusses how the organization designed a system of care to ensure that every…
Headline
The Department of Health and Human Services Dec. 11 published a final rule implementing provisions related to the Trusted Exchange Framework and Common…
Headline
In this conversation, Dave Eaker, geriatric program manager at Atrium Health, and Shannon Morton, assistant vice president of patient care services at Atrium…
Headline
In this conversation, Jennifer Richards, Ph.D., assistant professor at the Center for Indigenous Health, Johns Hopkins Bloomberg School of Public Health, and…
Headline
Registration is now open for AHA's 2025 Accelerating Health Equity Conference, May 19-22 in Atlanta, with an early-bird discount period through March 31. Join…
Headline
In this conversation, Kimberly Wozneak, national lead for age-friendly health systems at the Department of Veterans Affairs, discusses how the Veterans Health…